thiostrepton and osimertinib

thiostrepton has been researched along with osimertinib* in 1 studies

Other Studies

1 other study(ies) available for thiostrepton and osimertinib

Article	Year
c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression. Acta pharmacologica Sinica, 2022, Volume: 43, Issue:11 Topics: Animals; Carcinoma, Non-Small-Cell Lung; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Thiostrepton	2022

Article

Year

c-FLIP promotes drug resistance in non-small-cell lung cancer cells via upregulating FoxM1 expression.

Acta pharmacologica Sinica, 2022, Volume: 43, Issue:11

Topics: Animals; Carcinoma, Non-Small-Cell Lung; CASP8 and FADD-Like Apoptosis Regulating Protein; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Thiostrepton

2022